SEO URLwww.firestrike.ai/deals/penumbra-boston-scientific-acquisition-2026-1
acquisitionAnnounced · Jan 28, 2026Medical DevicesSource · CredibleArticle · Factual
Boston Scientific acquires Penumbra
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$14.5B
Target
Penumbra
Acquirer
Boston Scientific
Full Acquisition
Status
Pending
Boston Scientific agreed to acquire Penumbra. Reported deal value: $14.5B. Status: Pending. Sector: Medical Devices. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-01-28. Figures and status may change as filings and press coverage update.
By bringing Penumbra industry-leading mechanical thrombectomy and embolization technologies under its wing, Boston Scientific ( NYSE: BSX ) is positioning itself to become an undisputed titan in the treatment of stroke, pulmonary embolism, and deep vein thrombosis
Deal timeline
Announced
Jan 28, 2026 · markets.chroniclejournal.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Medical Devices with a reported deal value of $14.5B. Figures and status may change as sources update.
Sources: markets.chroniclejournal.com · Primary article · FireStrike proprietary index